San Diego, CA, United States of America

Daan Witters

This inventor holds 36 USPTO granted patents and 28 published patent applications, primarily in Nucleic Acid Sequencing. Top assignees: Singular Genomics Systems, Inc., California Institute of Technology, First-Citizens Bank & Trust Company. Active years: 2021-2026.

USPTO Granted Patents = 36 

% Patents Active = 91.7

Average Co-Inventor Count = 3.3

ph-index = 4

Forward Citations = 80(Granted Patents)


Company Filing History:


Years Active: 2021-2026

Loading Chart...
Areas of Expertise:
Nucleic Acid Sequencing
Multiplexed Targeted Amplification
Circular Polynucleotides
Nanoarrays
Polynucleotide Amplification
Mixtures Separation
Analyte Detection
Nucleic Acid Delivery
High Density Sequencing
Oligonucleotides
Linked Paired Strand Sequencing
Compositions
36 patents (USPTO):Explore Patents

Title: Daan Witters: Pioneering Inventor from San Diego

Introduction: Daan Witters is a renowned inventor based in San Diego, CA, known for his groundbreaking contributions to various fields of technology and innovation.

Latest Patents: Daan Witters holds several patents in the areas of renewable energy, artificial intelligence, and biotechnology, showcasing his diverse range of expertise and innovative thinking.

Career Highlights: With a career spanning over two decades, Daan Witters has worked with leading research institutions and tech companies, consistently pushing the boundaries of what is possible in the world of inventions.

Collaborations: Throughout his career, Daan Witters has collaborated with top scientists, engineers, and inventors globally, fostering a culture of innovation and knowledge sharing that has led to numerous successful projects and patents.

Conclusion: Daan Witters continues to inspire the next generation of inventors with his passion for innovation and his relentless pursuit of turning revolutionary ideas into tangible solutions that shape the future.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…